170 related articles for article (PubMed ID: 35811776)
1. Comprehensive Analysis of the E2F Transcription Factor Family in Human Lung Adenocarcinoma.
Wang Q; Liu J; Cheang I; Li J; Chen T; Li Y; Yu B
Int J Gen Med; 2022; 15():5973-5984. PubMed ID: 35811776
[TBL] [Abstract][Full Text] [Related]
2. E2F7 serves as a potential prognostic biomarker for lung adenocarcinoma.
Lin S; Yu X; Yan H; Xu Y; Ma K; Wang X; Liu Y; Xie A; Yu Z
Medicine (Baltimore); 2024 Jan; 103(3):e34342. PubMed ID: 38241554
[TBL] [Abstract][Full Text] [Related]
3. [The Expression of RTN1 in Lung Adenocarcinoma and
Its Effect on Immune Microenvironment].
Zhu S; Zu L; Xu S
Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic role of E2F transcription factors in high-grade glioma.
Yu H; Li Z; Wang M
CNS Neurosci Ther; 2020 Jul; 26(7):741-753. PubMed ID: 32064771
[TBL] [Abstract][Full Text] [Related]
5. Systematic Analysis of E2F Expression and Its Relation in Colorectal Cancer Prognosis.
Xu Z; Qu H; Ren Y; Gong Z; Ri HJ; Zhang F; Shao S; Chen X; Chen X
Int J Gen Med; 2022; 15():4849-4870. PubMed ID: 35585998
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
7. High expression of E2F transcription factors 7: An independent predictor of poor prognosis in patients with lung adenocarcinoma.
Zhang Y; Lyu L; Wang W; Zhang L
Medicine (Baltimore); 2022 Aug; 101(33):e29253. PubMed ID: 35984189
[TBL] [Abstract][Full Text] [Related]
8. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
9. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
[TBL] [Abstract][Full Text] [Related]
10. Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma.
Yuan Y; Xie B; Guo D; Liu C; Jiang G; Lai G; Zhang Y; Hu X; Wu Z; Zheng R; Huang L
Heliyon; 2023 Jul; 9(7):e18065. PubMed ID: 37539167
[TBL] [Abstract][Full Text] [Related]
11. Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma.
Li L; Li J
Front Oncol; 2023; 13():1128785. PubMed ID: 36959799
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
13. A bioinformatics analysis for diagnostic roles of the
Li J; Wang H; Cao F; Cheng Y
J Gastrointest Oncol; 2022 Oct; 13(5):2115-2131. PubMed ID: 36388667
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of Prognostic and Immune Infiltrates for E2F Transcription Factors in Human Pancreatic Adenocarcinoma.
Liu XS; Gao Y; Liu C; Chen XQ; Zhou LM; Yang JW; Kui XY; Pei ZJ
Front Oncol; 2020; 10():606735. PubMed ID: 33604289
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Values of E2F1/2 Transcriptional Expressions in Chromophobe Renal Cell Carcinoma Patients: Evidence from Bioinformatics Analysis.
Hu D; Meng N; Lou X; Li Z; Teng Y; Tu B; Zou Y; Wang F
Int J Gen Med; 2021; 14():3593-3609. PubMed ID: 34295182
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma.
Liu W; Jiang K; Wang J; Mei T; Zhao M; Huang D
Front Mol Biosci; 2021; 8():605754. PubMed ID: 33842535
[TBL] [Abstract][Full Text] [Related]
18. Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma.
Zheng X; Li Y; Ma C; Zhang J; Zhang Y; Fu Z; Luo H
Biomed Res Int; 2020; 2020():8851437. PubMed ID: 33178836
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of the functional and prognostic value of E2F transcription factors in human prostate cancer through data mining and experimental validation.
Wang D; Tang W; Zhang P; Liu Z; Lyu F; Xiao Y; Ni D; Zhang P
Transl Cancer Res; 2021 Dec; 10(12):5095-5109. PubMed ID: 35116361
[TBL] [Abstract][Full Text] [Related]
20. Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis.
Gao Z; Shi R; Yuan K; Wang Y
Tumour Biol; 2016 Nov; 37(11):14979-14987. PubMed ID: 27655285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
